<?xml version="1.0" encoding="UTF-8"?>
<p>Despite the introduction of DengvaxiaÂ®, a vaccine against DENV, the WHO has only recommended the introduction of the vaccine in geographic areas with high burden of disease. Moreover, this vaccine cannot be administered in children younger than 9 years old, because it has been demonstrate the increase of hospitalization risk in this age group (
 <xref rid="B91" ref-type="bibr">91</xref>), an important susceptible group, specially infant born from DENV-immune mothers.
</p>
